Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-08-23 00:00:00 ET · period of report 2024-08-21 · accession 0001843568-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-23 | 2024-08-21 | MYGN | Ancona Margaret | SVP, Chief of Staff | S - Sale | $27.82 | -11.5K | 79.4K | -13% | -$321.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-21 | S | D | 11,538 | $27.82 | 79,366 | D | — | — |